The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017.

Tissue Engineering. Part a
Max H P GayIvan Martin

Abstract

This report describes activity in Europe for the years 2016 and 2017 in the area of cellular and tissue-engineered therapies, excluding hematopoietic stem cell treatments for the reconstitution of hematopoiesis. It is the eighth of its kind and is supported by five established scientific organizations. In 2016 and 2017, a combined 234 teams from 29 countries responded to the cellular and engineered tissue therapy survey; 227 teams reported treating 8236 patients in these 2 years. Indications were categorized in hematology/oncology (40%; predominantly prevention or treatment of graft vs. host disease and hematopoietic graft enhancement), musculoskeletal/rheumatological disorders (29%), cardiovascular disorders (6%), neurological disorders (4%), gastrointestinal disorders (<1%), as well as miscellaneous disorders (20%), which were not assigned to the previous indications. The predominantly used cells were autologous (61%). The majority of autologous cells were used to treat musculoskeletal/rheumatological (44%) disorders, whereas allogeneic cells were mainly used for hematology/oncology (78%). The reported cell types were mesenchymal stem/stromal cells (MSCs) (56%), hematopoietic cells (21%), keratinocytes (7%), chondrocytes (6%)...Continue Reading

References

Nov 12, 2009·Regenerative Medicine·Chris Mason, Peter Dunnill
Feb 27, 2010·Tissue Engineering. Part a·Ivan MartinAlois Gratwohl
May 6, 2011·Tissue Engineering. Part a·Ivan MartinAlan Tyndall
Jun 14, 2012·Tissue Engineering. Part a·Ivan MartinAlan Tyndall
Oct 5, 2013·Tissue Engineering. Part a·Ivan MartinAlan Tyndall
Nov 27, 2014·Tissue Engineering. Part a·Ivan MartinJakob Passweg
Aug 19, 2015·Methods : a Companion to Methods in Enzymology·Hannah B BakerNancy M P King
Dec 15, 2015·Tissue Engineering. Part a·Ivan MartinJakob Passweg
Mar 16, 2017·The New England Journal of Medicine·Ajay E KuriyanJeffrey L Goldberg
Oct 11, 2017·Cytotherapy·Hilary IrelandUNKNOWN European Group for Blood and Marrow Transplantation
Mar 16, 2018·Bone Marrow Transplantation·Jakob R PasswegUNKNOWN European Society for Blood and Marrow Transplantation (EBMT)
Feb 8, 2019·Bone Marrow Transplantation·Jakob R PasswegUNKNOWN European Society for Blood and Marrow Transplantation (EBMT)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.